Viral load speaks little about toll on liver

Hepatobiliary and Pancreatic Diseases International

Volumn 6, Issue 5, 2007, Pages 483-486

  Mahtab, Mamun Al ^a   Rahman, Salimur ^a   Khan, Mobin ^a   Kamal, Md ^a   Al Mamun, Ayub ^a   Karim, Md Fazal ^a  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

Author keywords

Chronic hepatitis B; HBV DNA; Hepatic fibrosis; Hepatic necro inflammation

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; VIRUS LOAD; VIRUS MUTANT; WILD TYPE;

ADOLESCENT; ADULT; BIOPSY; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VIRAL LOAD;

EID: 34948906326     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Tibbs CJ, Smith HM. Clinicians guide to viral hepatitis. 1st Edition 2001, Arnold.
2. Mahtab MA, Rahman S. Correlation between serum transaminase level and HAI score in chronic hepatitis B. Ind J Gastroenterol 2005;24:124.
3. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 2006;4:936-962. Epub 2006 Jul 14.
4. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-435.
5. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-1520.
6. Benhava B, Assari S, Amini M, Hajibeiji B, Jouybari HM, Alavin SM. HBV DNA load and chronic hepatitis infection in different stages. Hep Monthly 2005;5:123-127.
7. Yuen MF, Ng IO, Fan ST, Yuan HJ, Wong DK, Yuen JC, et al. Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis B. Am J Gastroenterol 2004;99:2032-2037.
8. Lindh M, Horal P, Dhillon AP, Norkrans G. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat 2000;7:258-267.
9. Chu CJ, Lok AS. Clinical utility in quantifying serum HBV DNA levels using PCR assays. J Hepatol 2002;36:549-551.
10. Heo J, Baik TH, Kim HH, Kim GH, Kang DH, Song GA, et al. Serum hepatitis B virus (HBV) DNA levels at different stages of clinical course in patients with chronic HBV infection in an endemic area. J Korean Med Sci 2003;18:686-690.
11. Chan HL, Tsang SW, Liew CT, Tse CH, Wong ML, Ching JY, et al. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection. Am J Gastroenterol 2002;97:406-412.
12. Sakugawa H, Nakasone H, Nakayoshi T, Kawakami Y, Yamashiro T, Maeshiro T, et al. Correlation between serum transaminase activity and virus load among patients with chronic liver disease type B. Hepatol Res 2001;21:159-168.
13. Yalcin K, Degertekin H, Yildiz F, Celik Y. Markers of disease activity in chronic hepatitis B virus infection. Clin Invest Med 2003;26:27-34.
14. Xie Y, Zhao H, Dai WS, Xu DZ. HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 2003;2:418-422.
15. Chun YK, Kim JY, Woo HJ, Oh SM, Kang I, Ha J, et al. No significant correlation exists between core promoter mutations, viral replication, and liver damage in chronic hepatitis B infection. Hepatology 2000;32:1154-1162.
16. Habersetzer F, Zoulim F, Jusot JF, Zhang X, Trabaud MA, Chevallier P, et al. Clinical evaluation of the branched DNA assay for hepatitis B virus DNA detection in patients with chronic hepatitis B lacking hepatitis B e antigen and treated with interferon-alpha. J Viral Hepat 1998;5:407-414.